Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Details for Australian Patent Application No. 2003228284 (hide)

Owner CURAGEN CORPORATION

Inventors Chaudhuri, Amitabha; Qian, Xiazhong; Miller, Charles E; Vernet, Corine A. M.; Rieger, Daniel K.; Stone, David J; Anderson, David W; Voss, Edward Z; Gangolli, Esha A; Boldog, Ferenc L; Smithson, Glennda; Millet, Isabelle; Peyman, John; Alsobrook, John P II; Spytek, Kimberly A; Li, Li; Gorman, Linda; Rastelli, Luca; Patturajan, Meera; Zhong, Mei; Padigaru, Muralidhara; Mezes, Peter S; Kekuda, Ramesh; Ettenberg, Seth; Edinger, Shlomit R; Colman, Steven D; Sukumaran, Sujatha; Maclachlan, Timothy; Malyankar, Ur

Agent Cullens

Pub. Number AU-A-2003228284

PCT Number PCT/US03/06794

PCT Pub. Number WO2003/076578

Priority 60/365,034 15.03.02 US; 60/365,477 19.03.02 US; 60/365,984 20.03.02 US; 60/365,985 20.03.02 US; 60/365,884 20.03.02 US; 60/366,928 22.03.02 US; 60/372,018 12.04.02 US; 60/372,022 12.04.02 US; 60/374,682 23.04.02 US; 60/388,096 12.06.02 US; 60/389,143 14.06.02 US; 60/391,779 26.06.02 US; 60/403,743 15.08.02 US; 60/410,755 13.09.02 US; 60/412,957 23.09.02 US; 60/420,382 22.10.02 US; Not Given 05.03.03 US; 60/361,974 06.03.02 US; 10/093,463 08.03.02 US; PCT/US02/07288 08.03.02 US

Filing date 6 March 2003

Wipo publication date 22 September 2003

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/365,034 15.03.02 US; 60/365,477 19.03.02 US; 60/365,984 20.03.02 US; 60/365,985 20.03.02 US; 60/365,884 20.03.02 US; 60/366,928 22.03.02 US; 60/372,018 12.04.02 US; 60/372,022 12.04.02 US; 60/374,682 23.04.02 US; 60/388,096 12.06.02 US; 60/389,143 14.06.02 US; 60/391,779 26.06.02 US; 60/403,743 15.08.02 US; 60/410,755 13.09.02 US; 60/412,957 23.09.02 US; 60/420,382 22.10.02 US; Not Given 05.03.03 US; 60/361,974 06.03.02 US; 10/093,463 08.03.02 US; PCT/US02/07288 08.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003228284

21 September 2006 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Vernet, Corine A to Vernet, Corine A. M.

2 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228285-MULTIPLEXED ANALYSIS OF CELLULAR RESPONSES USING ENDOGENOUS REPORTER GENES

2003228283-QUINAZOLINONE MODULATORS OF NUCLEAR RECEPTORS